Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

{"This":[0,148,288],"narrative":[1],"review":[2,289],"examines":[3],"the":[4,27,42,77,120,187,295],"intricate":[5],"relationship":[6],"between":[7,297],"chronic":[8,47],"kidney":[9,48],"disease-mineral":[10],"and":[11,15,26,60,79,86,94,111,154,177,184,193,203,222,237,248,258,279,300],"bone":[12],"disorder":[13],"(CKD-MBD)":[14],"vascular":[16],"calcification":[17],"(VC),":[18],"with":[19,172],"particular":[20],"emphasis":[21],"on":[22,67,228],"hyperphosphatemia-driven":[23],"pathological":[24],"mechanisms":[25],"recognized":[28],"limitations":[29],"of":[30,82,104,122,189,303],"existing":[31],"therapeutic":[32],"approaches.":[33],"We":[34],"further":[35,260],"explore":[36],"emerging":[37],"strategies":[38,292],"designed":[39],"to":[40,115,199,269,284,293],"address":[41],"\\"phosphate":[43],"storm\\"":[44],"phenomenon":[45],"in":[46,74,170],"disease":[49],"(CKD),":[50],"offering":[51],"a":[52,101,130,233],"comprehensive":[53],"analysis":[54],"derived":[55],"from":[56,100],"recent":[57],"clinical":[58,78,112,160,195,207,261],"studies":[59],"mechanistic":[61],"research.":[62],"Our":[63],"evaluation":[64],"specifically":[65],"focuses":[66],"three":[68],"central":[69],"aspects:":[70],"dysregulated":[71],"phosphate":[72,84,140,173,182,217,275],"metabolism":[73],"VC":[75,224],"progression,":[76],"physiological":[80],"constraints":[81],"conventional":[83,190],"binders,":[85,174],"novel":[87],"interventions":[88],"such":[89],"as":[90,129,167],"Tenapanor,":[91],"vitamin":[92,175],"K₂,":[93],"magnesium":[95,247],"supplementation.":[96],"Data":[97],"were":[98],"synthesized":[99],"wide":[102],"array":[103],"sources":[105],"including":[106],"epidemiological":[107],"studies,":[108],"animal":[109],"models,":[110],"trials,":[113],"leading":[114],"four":[116],"principal":[117],"findings:":[118],"1.From":[119],"perspective":[121],"expert":[123,229],"opinion,":[124],"early":[125],"intervention":[126],"is":[127,146,150,155],"proposed":[128],"hypothesis-generating":[131],"strategy.":[132],"Phosphate-lowering":[133],"therapy":[134],"could":[135,212],"be":[136],"initiated":[137],"when":[138],"serum":[139,216,244,246],"exceeds":[141],"3.9":[142],"mg/dL":[143],"or":[144,162,169],"FGF-23":[145],"elevated.":[147],"threshold":[149],"an":[151],"exploratory":[152,240],"reference":[153,241],"not":[156,214,254],"endorsed":[157],"by":[158],"high-quality":[159],"evidence":[161],"international":[163],"guidelines.":[164],"2.Tenapanor,":[165],"either":[166],"monotherapy":[168],"combination":[171],"K2":[176],"magnesium,":[178],"effectively":[179],"decreases":[180],"intestinal":[181],"absorption":[183],"may":[185],"overcome":[186],"drawbacks":[188],"treatments.":[191],"Large":[192],"long-term":[194],"trials":[196],"are":[197,253],"required":[198],"confirm":[200],"its":[201],"safety":[202],"efficacy":[204],"for":[205,243],"routine":[206],"use.":[208],"3.":[209],"Multimodal":[210],"monitoring":[211],"include":[213],"only":[215],"but":[218],"also":[219],"FGF-23,":[220],"dp-ucMGP,":[221],"annual":[223],"assessment.":[225],"4.":[226],"Based":[227],"opinions,":[230],"we":[231],"developed":[232],"triad":[234],"balance":[235],"strategy":[236],"put":[238],"forward":[239],"ranges":[242],"phosphate,":[245],"corrected":[249],"calcium.":[250],"These":[251],"values":[252],"formal":[255],"guideline":[256],"targets":[257],"require":[259],"validation.":[262],"In":[263],"conclusion,":[264],"while":[265],"phosphate-centric":[266],"management":[267],"fails":[268],"halt":[270],"VC,":[271],"multitargeted":[272],"strategies-integrating":[273],"controlled":[274],"absorption,":[276],"anti-calcification":[277],"agents,":[278],"personalized":[280],"monitoring-show":[281],"strong":[282],"potential":[283],"improve":[285],"CKD-MBD":[286],"outcomes.":[287],"proposes":[290],"paradigm-shifting":[291],"bridge":[294],"gap":[296],"biochemical":[298],"control":[299],"actual":[301],"prevention":[302],"VC.":[304]}